Cell based Assays Market

Thermo Fisher Scientific (US) and Danaher Corporation (US) are Leading players in the Cell based Assays Market

The global cell-based assays market is projected to reach USD 28.2 billion by 2028 from USD 18.9 billion in 2023, at a CAGR of 8.4% during the forecast period of 2023 to 2028. The growth of this market is majorly by the the escalating demand for drug discovery and development, with a particular preference for cell-based assays in the drug discovery process. The market also benefits from strong government support and funding for cell-based research, as well as the FDA's active efforts to reduce reliance on animal-based studies.

The global cell-based assays market is a consolidated market, with Danaher Corporation (US), Thermo Fisher Scientific (US), Merck (Germany), and Becton, Dickinson and Company (US) together accounting for ~50–60% of the global market.

To know about the assumptions considered for the study download the pdf brochure

Thermo Fisher Scientific (US)

Thermo Fisher Scientific is one of the leading players in the life science industry, with a strong market presence in more than 80 countries. The company is involved in developing, manufacturing, selling, and distributing analytical instruments, equipment, reagents & consumables, software, and services. The company operates through four key segments—Laboratory Products & Biopharma Services, Life Sciences Solutions, Analytical Instruments, and Specialty Diagnostics. The company offers cell-based assay kits and instruments under its Life Sciences Solutions segment.

The company has a strong geographic presence in more than 50 countries across the Asia Pacific, North America, Europe, and Latin America. Some of its major subsidiaries include Laboratory Management Systems, Inc. (US), Thermo Dutch Holdings Limited Partnership (UK), Thermo EGS Gauging LLC (US), Fisher Clinical Services Limited Liability Company (Russia), Fisher Clinical Services Japan K.K., and Thermo Fisher Scientific C.V. (Netherlands).

Danaher Corporation (US)

Danaher Corporation designs, manufactures, and sells professional, medical, industrial, and commercial products & services. The company operates through four business segments—Life Sciences, Diagnostics, Biotechnology, and Environmental & Applied Solutions. The Biotechnology and Life Sciences segments offer a wide range of cell-based assay products & services, such as analytical instruments, reagents, consumables, software, and services for research, analysis, manufacturing, and drug discovery.

Danaher operates in over 60 countries, inclusive of approximately 261 offices, R&D centers, and manufacturing & distribution facilities in North America, Europe, Asia, South America, and Australia. Some of the most notable subsidiaries of Danaher include Pall (Canada) Limited, Pall (Schweiz) AG (Switzerland), Pentron Corporation (Delaware), X-Rite Asia Pacific Limited (Hong Kong), and Pall Corporation (US).

Merck KGaA (Germany)

Merck KGaA offers products for the pharmaceutical & biopharmaceutical, specialty chemicals, high-tech materials, and life science sectors. Merck operates through three business segments—Healthcare, Life Science, and Performance Materials. The Life Science business segment consists of the Merck Millipore business and the acquired life science business of Sigma-Aldrich Corporation (US). In November 2015, Merck KGaA acquired Sigma-Aldrich Corporation (US), one of the leading players in the life science industry, in order to strengthen its Life Science product portfolio. The Life Science segment offers products such as instruments, consumables, and reagents & kits for cell biology and cell analysis. The Life Science sector of Merck operates through three subsegments—Science & Lab Solutions, Process Solutions, and Life Science Services.

The company has a strong presence in 66 countries across Europe, North America, Latin America, the Asia Pacific, and the Middle East & Africa. Its subsidiaries include Allergopharma GmbH (Germany), Merck Serono GmbH (Germany), Merck Life Science (Denmark), Merck Millipore (Ireland), Merck Consumer Healthcare (UK), Merck Serono Europe (UK), EMD Chemicals Canada, EMD Millipore Corporation (US), EMD Serono (US), Merck S.A. (Chile), Merck Pharmaceutical (HK) (China), InterPharm Industries (Israel), Merck (Thailand), Merck (New Zealand), Millipore Mauritius, and Merck (Japan).

Related Reports:

Cell based Assays Market by Product & Service (Reagents, Assays Kits, Cell Lines, Microplates, Probes & Labels, Instruments & Software), Application (Drug Discovery (Toxicity, Pharmacokinetics), Research), End User (CROS, Pharma) - Global Forecast to 2028

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]

Cell based Assays Market Size,  Share & Growth Report
Report Code
BT 2486
RI Published ON
6/20/2023
Choose License Type
BUY NOW
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

SEND ME A FREE SAMPLE
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2024 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status